Drug Interaction Report

Rifapentine and Apixaban: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Rifapentine

Priftin
+

Apixaban

Eliquis Eliquis®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 92 documented Rifapentine interactions, 56 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be weaker Theoretical
The Bottom Line
Rifapentine can lower apixaban levels and weaken its clot protection, so talk with your doctor or pharmacist; they may avoid the combination or monitor you closely rather than have you change anything on your own.

Rifapentine can make your apixaban (Eliquis) work less well. Apixaban is a blood thinner that helps prevent dangerous blood clots. Rifapentine speeds up the body's system that breaks apixaban down, so more of it gets cleared away and less stays in your blood. That could leave you with too little clot protection, which raises the risk of a clot, stroke, or DVT.

The good news is this is a known concern your care team can plan around. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor. They may watch you more closely or choose a different option that fits you better.

Effect: Reduced apixaban exposure via rifapentine-induced CYP3A4 metabolism (rifapentine is a strong CYP3A inducer; apixaban is a CYP3A/P-gp substrate). Neither drug is a prodrug, so induction translates directly to lower apixaban plasma concentrations and diminished anticoagulant effect, increasing thromboembolic risk.

  • Direction: decreased apixaban AUC/Cmax
  • Magnitude: potentially significant; not precisely quantified
  • Onset: unspecified (enzyme induction is typically delayed, developing over days)
  • Evidence: theoretical
  • Management: guidelines suggest avoiding coadministration or using cautiously with close clinical monitoring for thrombosis; manufacturer gives no specific dose adjustment for strong CYP3A inducers lacking P-gp induction.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Reduced apixaban exposure

Interaction Deep Dive

Taking apixaban (a CYP3A substrate) together with a potent CYP3A inducer can markedly lower apixaban concentrations 2. Although the manufacturer offers no specific recommendation regarding the combined use of apixaban with strong CYP3A inducers that do not additionally induce P-gp 1, clinical guidelines recommend either avoiding the combination or using it with caution alongside close monitoring 2.

Why it happens (mechanism)

Induction of CYP3A-mediated metabolism of apixaban

How to manage this interaction

Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Because rifapentine can lower apixaban levels, your protection against clots may drop.

  • Your care team may avoid using these together or use them cautiously with closer monitoring.
  • They may consider a different antibiotic or a different anticoagulant strategy that suits you.
  • Watch for and report signs of a clot: leg swelling or pain, sudden shortness of breath, chest pain, or stroke symptoms (face drooping, arm weakness, speech trouble).

Raise this combination with your pharmacist or prescriber so the plan can be tailored to you.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Rifapentine and Apixaban together?

Rifapentine can lower apixaban levels and weaken its clot protection, so talk with your doctor or pharmacist; they may avoid the combination or monitor you closely rather than have you change anything on your own. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Rifapentine and Apixaban interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Rifapentine and Apixaban interaction managed?

Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Because rifapentine can lower apixaban levels, your protection against clots may drop. Your care team may avoid using these together or use them cautiously with closer monitoring. They may consider a different antibiotic or a different anticoagulant strategy that suits you. Watch for and report signs of a c… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Rifapentine or Apixaban need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (2)

  1. Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
  2. Steffel J, Collins R, Antz M, et al: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021; 23(10):1612-1676.
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.